Long-term exposure can lead to mesothelioma ... Pre-existing lung conditions: Chronic respiratory diseases like emphysema and ...

Merck & Co. said Wednesday it will acquire London-based Verona Pharma in a $10 billion all-cash deal, bolstering its respiratory treatment portfolio as the company moves to reduce long-term dependence ...

Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD – ...

Experts are worried that despite the hard-won lessons of covid, we are not fully prepared for the next pandemic.

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

The prevalence of long COVID-typical symptom clusters was relatively high among a cohort of adults 2 years after initial COVID-19 infection.